NOVELION THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
NOVELION THERAPEUTICS INC. - More news...
NOVELION THERAPEUTICS INC. - More news...
- Novelion Therapeutics Provides Update on Liquidation Process
- Novelion Therapeutics Ceases to be a Reporting Issuer in Canada
- Novelion Therapeutics Provides Update on Liquidation and Claims Process
- Novelion Therapeutics Confirms Commencement of Voluntary Liquidation
- Novelion Therapeutics Announces January 16, 2020 Effective Date for Commencement of Voluntary Liquidation
- Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
- Novelion Therapeutics Provides Update on Effective Date of Liquidation
- Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
- Novelion Therapeutics Announces Results of 2019 Annual General Meeting of Shareholders
- Novelion Therapeutics Announces New Trading Symbol
- Novelion Therapeutics Announces Nasdaq Delisting
- Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters
- Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers
- Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders
- Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case
- Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
- Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019
- Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
- Novelion Therapeutics Responds to Whitefort Capital Petition
- Novelion Therapeutics Reports First Quarter 2019 Financial Results
- Novelion Therapeutics Observes World Lipodystrophy Day
- Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
- Novelion Therapeutics Observes Rare Disease Day
-
Novelion Therapeutics Inc. - NVLN Stock Chart Technical Analysis for 02-06-2019
- Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan
-
Novelion Therapeutics Inc. - NVLN Stock Chart Technical Analysis for 12-04-18
- Novelion Therapeutics Announces Leadership Change
-
Novelion Therapeutics Inc. - NVLN Stock Chart Technical Analysis for 11-09-18
- Novelion Therapeutics Reports Third Quarter 2018 Financial Results
-
Novelion Therapeutics Inc. - NVLN Stock Chart Technical Analysis for 11-08-18
